Biomarin Pharmaceutical Inc (BMRN)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 580,235 | 532,062 | 503,023 | 470,515 | 524,272 |
| Payables | US$ in thousands | 235,403 | 315,509 | 231,238 | 193,003 | 191,429 |
| Payables turnover | 2.46 | 1.69 | 2.18 | 2.44 | 2.74 |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $580,235K ÷ $235,403K
= 2.46
The payables turnover ratio for Biomarin Pharmaceutical Inc for the year ended December 31, 2020, and subsequent years through December 31, 2024, is not provided in the data. The payables turnover ratio indicates the efficiency with which a company manages its accounts payable by paying its suppliers. Without the specific values for each year, it is challenging to assess the company's ability to efficiently utilize its accounts payable balance. Further information or data is required to conduct a detailed analysis of Biomarin Pharmaceutical Inc's payables turnover.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
Biomarin Pharmaceutical Inc
BMRN
2.46
Arrowhead Pharmaceuticals Inc
ARWR
0.00
Regeneron Pharmaceuticals Inc
REGN
2.50